As of 2025-11-15, the Intrinsic Value of Outlook Therapeutics Inc (OTLK) is -6.51 USD. This OTLK valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.57 USD, the upside of Outlook Therapeutics Inc is -514.39%.
Based on its market price of 1.57 USD and our intrinsic valuation, Outlook Therapeutics Inc (OTLK) is overvalued by 514.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.51 - -6.51 | -6.51 | -514.39% |
| P/E | (21.34) - (21.68) | (21.47) | -1467.5% |
| DDM - Stable | (9.97) - (30.21) | (20.09) | -1379.9% |
| DDM - Multi | (15.93) - (38.00) | (22.50) | -1533.3% |
| Market Cap (mil) | 52.42 |
| Beta | 1.22 |
| Outstanding shares (mil) | 33.39 |
| Enterprise Value (mil) | 77.95 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.50% |
| Cost of Debt | 5.00% |
| WACC | 8.54% |